- Home
- AMST vs VRAX Comparison
AMST vs VRAX Comparison
Compare AMST & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- VRAX
- Stock Information
- Founded
- AMST 2017
- VRAX 2013
- Country
- AMST United States
- VRAX United Kingdom
- Employees
- AMST N/A
- VRAX N/A
- Industry
- AMST Computer Software: Prepackaged Software
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMST Technology
- VRAX Health Care
- Exchange
- AMST Nasdaq
- VRAX Nasdaq
- Market Cap
- AMST 7.4M
- VRAX 7.3M
- IPO Year
- AMST 2020
- VRAX 2022
- Fundamental
- Price
- AMST $2.40
- VRAX $1.29
- Analyst Decision
- AMST
- VRAX
- Analyst Count
- AMST 0
- VRAX 0
- Target Price
- AMST N/A
- VRAX N/A
- AVG Volume (30 Days)
- AMST 2.3M
- VRAX 194.7K
- Earning Date
- AMST 05-09-2025
- VRAX 02-05-2025
- Dividend Yield
- AMST N/A
- VRAX N/A
- EPS Growth
- AMST N/A
- VRAX N/A
- EPS
- AMST N/A
- VRAX N/A
- Revenue
- AMST $86,115.00
- VRAX $84,872.00
- Revenue This Year
- AMST N/A
- VRAX $5,169.18
- Revenue Next Year
- AMST N/A
- VRAX $66.97
- P/E Ratio
- AMST N/A
- VRAX N/A
- Revenue Growth
- AMST N/A
- VRAX 7.03
- 52 Week Low
- AMST $1.85
- VRAX $0.60
- 52 Week High
- AMST $6.27
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- AMST 40.40
- VRAX 33.99
- Support Level
- AMST $2.15
- VRAX $1.22
- Resistance Level
- AMST $2.54
- VRAX $1.84
- Average True Range (ATR)
- AMST 0.37
- VRAX 0.18
- MACD
- AMST 0.02
- VRAX -0.02
- Stochastic Oscillator
- AMST 13.00
- VRAX 9.59
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.